Evidence map›Paper›PMID 30157946›Full record

Trial reportBMC research notes2018

Vitamin D binding protein is not affected by high-dose vitamin D supplementation: a post hoc analysis of a randomised, placebo-controlled study.

Linda Björkhem-Bergman, Emelie Torefalk, Lena Ekström, Peter Bergman

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BMC research notes, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Observational
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Linda Björkhem-BergmanDivision of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society (NVS), Karolinska Institutet, Blickagången 16, Neo Floor 7, 141 83, Huddinge, Sweden. linda.bjorkhem-bergman@ki.se.
Emelie TorefalkDivision of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, F68, 141 86, Stockholm, Sweden.
Lena EkströmDivision of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet, C1-68, 141 86, Stockholm, Sweden.
Peter BergmanDivision of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, F68, 141 86, Stockholm, Sweden.
Karolinska Institutet · SE

Funding

Cancerfonden CAN 2015/249Cancerfonden CAN 2017/233Stockholms Läns Landsting 20130317Stockholms Läns Landsting ALFStockholms Läns Landsting ALF 20160036Vetenskapsrådet 2013-1047Vetenskapsrådet VR
6 · The paper itself

Abstract

objectivesVitamin D binding protein (VDBP) is the main transporter of 25-hydroxyvitamin D

resultsVDBP levels were not affected by vitamin D treatment, although the 25-OHD levels increased significantly in the vitamin D treated subjects. There was a strong correlation between 25-OHD and free 25-OHD (r

Indexed as

Carrier StateDouble-Blind MethodHumansMethicillin-Resistant Staphylococcus aureusVitamin DVitamin D-Binding ProteinVitamin D DeficiencyVitaminsVitamin DVitamin D-Binding ProteinVitaminsFree 25-hydroxyvitamin DMRSAVitamin DVitamin D binding protein

Identifiers

PMID30157946
PMCPMC6114541
OpenAlexW2889464304

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.